Cargando…
ePS4.06 Antibody response to administration of 2 doses of the BNT162b2 vaccine against SARS-CoV-2 in people with cystic fibrosis
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Cystic Fibrosis Society.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184774/ http://dx.doi.org/10.1016/S1569-1993(22)00314-9 |
| _version_ | 1784724601330204672 |
|---|---|
| author | Alicandro, G. Dacco’, V. Cariani, L. Contarini, M. Rosazza, C. Sciarrabba, C.S. Ferraro, F. Orena, B.S. Colombo, C. |
| author_facet | Alicandro, G. Dacco’, V. Cariani, L. Contarini, M. Rosazza, C. Sciarrabba, C.S. Ferraro, F. Orena, B.S. Colombo, C. |
| author_sort | Alicandro, G. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9184774 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | European Cystic Fibrosis Society. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-91847742022-06-10 ePS4.06 Antibody response to administration of 2 doses of the BNT162b2 vaccine against SARS-CoV-2 in people with cystic fibrosis Alicandro, G. Dacco’, V. Cariani, L. Contarini, M. Rosazza, C. Sciarrabba, C.S. Ferraro, F. Orena, B.S. Colombo, C. J Cyst Fibros E-Poster Sessions European Cystic Fibrosis Society. 2022-06 2022-06-10 /pmc/articles/PMC9184774/ http://dx.doi.org/10.1016/S1569-1993(22)00314-9 Text en Copyright © 2022 European Cystic Fibrosis Society. All rights reserved. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | E-Poster Sessions Alicandro, G. Dacco’, V. Cariani, L. Contarini, M. Rosazza, C. Sciarrabba, C.S. Ferraro, F. Orena, B.S. Colombo, C. ePS4.06 Antibody response to administration of 2 doses of the BNT162b2 vaccine against SARS-CoV-2 in people with cystic fibrosis |
| title | ePS4.06 Antibody response to administration of 2 doses of the BNT162b2 vaccine against SARS-CoV-2 in people with cystic fibrosis |
| title_full | ePS4.06 Antibody response to administration of 2 doses of the BNT162b2 vaccine against SARS-CoV-2 in people with cystic fibrosis |
| title_fullStr | ePS4.06 Antibody response to administration of 2 doses of the BNT162b2 vaccine against SARS-CoV-2 in people with cystic fibrosis |
| title_full_unstemmed | ePS4.06 Antibody response to administration of 2 doses of the BNT162b2 vaccine against SARS-CoV-2 in people with cystic fibrosis |
| title_short | ePS4.06 Antibody response to administration of 2 doses of the BNT162b2 vaccine against SARS-CoV-2 in people with cystic fibrosis |
| title_sort | eps4.06 antibody response to administration of 2 doses of the bnt162b2 vaccine against sars-cov-2 in people with cystic fibrosis |
| topic | E-Poster Sessions |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184774/ http://dx.doi.org/10.1016/S1569-1993(22)00314-9 |
| work_keys_str_mv | AT alicandrog eps406antibodyresponsetoadministrationof2dosesofthebnt162b2vaccineagainstsarscov2inpeoplewithcysticfibrosis AT daccov eps406antibodyresponsetoadministrationof2dosesofthebnt162b2vaccineagainstsarscov2inpeoplewithcysticfibrosis AT carianil eps406antibodyresponsetoadministrationof2dosesofthebnt162b2vaccineagainstsarscov2inpeoplewithcysticfibrosis AT contarinim eps406antibodyresponsetoadministrationof2dosesofthebnt162b2vaccineagainstsarscov2inpeoplewithcysticfibrosis AT rosazzac eps406antibodyresponsetoadministrationof2dosesofthebnt162b2vaccineagainstsarscov2inpeoplewithcysticfibrosis AT sciarrabbacs eps406antibodyresponsetoadministrationof2dosesofthebnt162b2vaccineagainstsarscov2inpeoplewithcysticfibrosis AT ferrarof eps406antibodyresponsetoadministrationof2dosesofthebnt162b2vaccineagainstsarscov2inpeoplewithcysticfibrosis AT orenabs eps406antibodyresponsetoadministrationof2dosesofthebnt162b2vaccineagainstsarscov2inpeoplewithcysticfibrosis AT colomboc eps406antibodyresponsetoadministrationof2dosesofthebnt162b2vaccineagainstsarscov2inpeoplewithcysticfibrosis |